Amino acid or protein metabolism disease with epilepsy

Amino acid or protein metabolism disease with epilepsy (Orphanet code 225689) is not a single disease entity but rather a classification group used by Orphanet to categorize a collection of inherited metabolic disorders that share two key features: a primary defect in amino acid or protein metabolism and the presence of epilepsy (seizures) as a significant clinical manifestation. This grouping encompasses a wide range of inborn errors of metabolism, including but not limited to conditions such as phenylketonuria (when poorly controlled), maple syrup urine disease, nonketotic hyperglycinemia (glycine encephalopathy), sulfite oxidase deficiency, serine biosynthesis defects, and various organic acidurias. These disorders result from deficient or dysfunctional enzymes or transporters involved in amino acid or protein metabolic pathways, leading to toxic accumulation of substrates or deficiency of essential metabolic products. The body systems most commonly affected include the central nervous system, where the accumulation of toxic metabolites or deficiency of critical amino acid-derived neurotransmitters leads to seizures, developmental delay, intellectual disability, and progressive neurological deterioration. Other systems that may be involved depending on the specific underlying condition include the liver, kidneys, eyes, and musculoskeletal system. Epilepsy in these conditions can range from neonatal-onset severe epileptic encephalopathy to later-onset seizure disorders, and seizure types vary widely across the individual diseases within this group. Treatment approaches depend on the specific underlying metabolic disorder and may include dietary restriction of the offending amino acid(s), supplementation of deficient metabolites or cofactors (such as pyridoxine, folinic acid, or serine), use of nitrogen-scavenging agents, antiepileptic medications, and in some cases liver transplantation or enzyme replacement therapy. Early diagnosis through newborn screening programs, where available, can significantly improve outcomes for several conditions within this group. Management typically requires a multidisciplinary team including metabolic specialists, neurologists, dietitians, and genetic counselors.

Common questions about Amino acid or protein metabolism disease with epilepsy